# Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)

Canonical: https://abierto.us/opportunities/noticeofintenttosolesourcedevelopmentandvalidationofdiagnosticmethodsforcoccidioidomycosisvalleyfever

- Solicitation number: Notice_of_Intent_to_Sole_Source_Development_and_Validation_of_Diagnostic_Methods_for_Coccidioidomycosis_(Valley_Fever)
- Notice type: Special notice
- Status: Closed. Deadline was July 29, 2026 at 11:00 AM EDT
- Department: Department of Health and Human Services
- Agency: Centers for Disease Control and Prevention
- Contracting office: CDC Office of Acquisition Services (75D301)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AN12 Health R&D Services; Health Care Services; Applied Research
- Set-aside: Total small business set-aside
- Place of performance: Tucson, Arizona
- First posted: July 15, 2026
- Last posted: July 15, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/1df7bbf0cd7f4da1b92b4be25e8a4942/view

## Description

Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever) The Centers for Disease Control and Prevention intends to award a sole source firm fixed price to Valley fever Solutions, INC, Valley Fever Center for Excellence (University of Arizona) to support the development, evaluation, and validation of diagnostic methods for coccidioidomycosis through collaboration with the Valley Fever Center for Excellence (VFCE).

This project will leverage VFCE’s existing biospecimen repository and clinical infrastructure to support diagnostic assay development. Additional specimen collection and enhanced storage capacity will be implemented to support expanded research needs.

**Product or Service Code:** AN12 – Health R&D Services;

**Applied Research NAICS Code:** 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) The anticipated period of performance is September 30, 2026, to September 29, 2027 Place of Performance: All work under this contract shall be performed at the contractor’s facilities, specifically the Valley Fever Center for Excellence (VFCE), located within the United States. No work will be performed at CDC facilities.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government.

A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Contract Specialist at dwb7@cdc.gov by 11:00AM (ET) on 07/29/2026.

## Publications

- July 15, 2026: Special notice, due July 29, 2026 at 11:00 AM EDT. Notice 1df7bbf0cd7f4da1b92b4be25e8a4942. https://sam.gov/workspace/contract/opp/1df7bbf0cd7f4da1b92b4be25e8a4942/view

## Points of contact

- Marquetta Taylor, dwb7@cdc.gov, 7704883295

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/noticeofintenttosolesourcedevelopmentandvalidationofdiagnosticmethodsforcoccidioidomycosisvalleyfever.